Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voxelotor for Functional Capacity in Sickle Cell Disease
NCT06023199Phase 2Completed
- Sponsor
- Inova Health System
- Start
- Oct 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of voxelotor in sickle cell disease (SCD), sponsored by Inova Health System. Started Oct 2023; status: completed.
02
Drugs
voxelotor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT06023199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06023199.